Related Experiment Videos
Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms
1Artificial Cells & Organs Research Centre, McGill University, 3655 Drummond Street, Room 1005, Montreal, Quebec, Canada, H3G 1Y6.
Molecular Biotechnology
|July 4, 2001
Summary
This study details microencapsulation methods for enzymes, cells, and engineered bacteria. These techniques offer potential treatments for metabolic disorders, liver failure, and kidney failure.
Area of Science:
- Biotechnology
- Biomaterials Science
- Cell Biology
Background:
- Microencapsulation is a key technology for delivering therapeutic agents.
- Existing methods have limitations in encapsulating specific cell types or complex systems.
- There is a need for advanced microencapsulation techniques for various medical applications.
Purpose of the Study:
- To present comprehensive methods for microencapsulating enzymes, cells, and genetically engineered cells.
- To highlight novel approaches for enhanced therapeutic delivery and metabolic correction.
- To provide detailed protocols for specific clinical applications.
Main Methods:
- Described microencapsulation of enzymes like xanthine oxidase and phenylalanine ammonia lyase.
- Detailed cell encapsulation protocols for hepatocytes and a novel two-step method for small cells.
- Presented a method for encapsulating genetically engineered Escherichia coli for metabolite reduction.
Main Results:
- Successful microencapsulation of enzymes for specific metabolic diseases (Lesch-Nyhan, phenylketonuria).
- Demonstrated encapsulation of hepatocytes for liver failure and gene therapy applications.
- Showcased encapsulation of engineered E. coli for managing urea and ammonia in kidney/liver failure.
Conclusions:
- Microencapsulation offers versatile solutions for enzyme and cell-based therapies.
- Novel methods enhance the encapsulation of diverse biological materials for disease treatment.
- These advancements hold promise for treating metabolic disorders and organ failure.